A venture capital company based in California is currently making investments out of a $200 million fund. The firm makes seed and initial venture investments into companies ranging from $500K to $5 million, depending on the stage and financial requirements of the company – up to $15 million during the company’s lifetime.The firm has a preference for companies based in Silicon Valley, but will consider opportunities globally and looks to make around 5-6 more new investments from the current fund.
The firm is sector agnostic, and its main screening criteria is that the company is operating in a white space (meaning little or no competition) area and having potential market sizes of at least $10 billion. That being said, in the life science space the firm is most interested in medical technology, devices, and diagnostics for massive unmet markets such as diabetes and obesity. Additionally, the firm is interested in lab and provider service companies, although the firm is very sensitive to market size (need to meet the aforementioned market size). The firm has experience in the diagnostic and bioinformatic sectors.
The firm looks to be the first institutional investor in companies and acts as a lead investor. The firm looks to take an active board seat into companies and assist with many aspects of the company’s development. The firm looks for experienced management teams and a history of success is a strong plus.
If you are interested in more information about this investor and other investors tracked by LSN, please email mandates@lifesciencenation.com
Next Phase Newsletter 
Leave a comment